04/17/2024 3:18 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 7:01 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 3:44 PM | Haemonetics (Issuer) Simon, Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 5:10 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 2:28 PM | Haemonetics (Subject) Neuberger Berman Group LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 4:49 PM | Capital Research Global Investors (Filed by) Haemonetics (Subject)
| Form SC 13G/A | |
02/08/2024 9:21 AM | Haemonetics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
|
02/08/2024 5:05 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/08/2024 5:06 AM | Haemonetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
12/12/2023 5:09 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 3:36 PM | Galvin Roy (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 5:19 AM | Haemonetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 5:16 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 3:23 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 3:27 PM | Basil Michelle L (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 5:10 AM | Haemonetics (Filer)
| Form 8-K/A | |
10/10/2023 5:06 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 3:16 PM | Haemonetics (Issuer) Miller Laurie A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 3:19 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 3:20 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 11:19 AM | Haemonetics (Subject) Strong Stewart W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 12:22 PM | Haemonetics (Subject) Lingamneni Anila (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:23 PM | Dockendorff Charles J (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 1:23 PM | Dockendorff Charles J (Reporting) Haemonetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023 5:09 AM | Haemonetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023 5:01 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/20/2023 3:17 PM | Haemonetics (Issuer) Llorens Josep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 11:55 AM | Haemonetics (Subject) Llorens Josep (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023 3:17 PM | Haemonetics (Issuer) Simon, Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:14 AM | Haemonetics (Filer)
| Form ARS | |
06/16/2023 5:08 AM | Haemonetics (Filer)
| Form DEF 14A | |
06/16/2023 5:10 AM | Haemonetics (Filer)
| Form DEFA14A | |
06/07/2023 1:03 PM | Haemonetics (Subject) Strong Stewart W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023 3:19 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 9:23 AM | Haemonetics (Subject) Lingamneni Anila (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023 3:37 PM | Basil Michelle L (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 3:34 PM | Haemonetics (Issuer) Miller Laurie A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 3:35 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2023 3:36 PM | Haemonetics (Issuer) Maunsell Farris Maryanne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2023 3:16 PM | Haemonetics (Issuer) Llorens Josep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2023 3:17 PM | Basil Michelle L (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
What is Medicare Supplement Insurance? (Ad) Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here |
05/11/2023 5:05 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |